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A B S T R A C T
The aim of this research was to evaluate the fractions obtained from the leaf, stem and 
roots of Allamanda schottii, Pohl, Apocynaceae, responsible for the cytotoxicity, using several 
cell lines. Cytotoxicity was correlated with the season the part of the plant, and the major 
compounds were assessed. The ethanol extracts of leaves, stems and roots obtained at dif-
ferent seasons were evaluated in the human erythromyeloblastoid leukemia cell line (K562). 
Subsequently the ethanol extracts and dichloromethane fractions collected in winter were 
evaluated in mouse fibroblast cell line (Mus musculus) (L929), cervix adenocarcinoma (HeLa), 
human pre-B leukemia (Nalm6), as well as K562 cell line. The compounds plumericin, plum-
ieride and ursolic acid isolated from ethanol extracts of the stems were evaluated in the 
same cell lines, as well as on breast adenocarcinoma cell line (MCF-7), and Mus musculus 
skin melanoma cell line (B16F10). The chromatographic profiles of the dichloromethane 
fractions were obtained by high performance liquid chromatography. The results revealed 
that the season during which A. schottii was collected, and the part of the plant analyzed, 
influence the cytotoxicity on the K562 cells tested. On the other hand the dichloromethane 
fractions, mainly from the stems and roots, are responsible for the cytoxicity on the cells 
tested. These results may be associated with the seasonal variation of plumericin in these 
parts of the plant. This information is in accordance with the HPLC analysis. The results 
clearly show the potential for the phytotherapeutic use of this species, and suggest that 
the cytotoxic activity observed may be due to the presence of plumericin, or to minor com-
pounds not yet identified. The seasonal influence on the production of secondary metabo-
lites was verified.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction
The search for substances with antitumor potential has 
significantly expanded the study of natural products. Plants 
have provided an extraordinary source of new compounds with 
therapeutic activity and the secondary metabolites represents 
an efficient alternative for obtaining new drugs. Plants have 
an important role as a source of antitumoral agents, and over 
67% of anti-cancer drugs currently in use are derived from 
natural sources (Cragg and Newman, 2012). It is important 
to note that the production of these metabolites in plants is 
related to adaptive processes in response to factors such as 
climatic differences, stress levels, water availability, light, and 
natural predators (Gobbo-Neto and Lopes, 2007). The amount 
and nature of these compounds is not constant throughout the 
year, and they are not produced by all parts of the plant. These 
aspects are important considerations to guide studies that aim 
to the isolation of natural products. In addition, bio-directed 
studies could potentially reduce the number of stages required 
to identify active compounds in plants.
Allamanda, Apocynaceae, is a genus of climbing shrubs, 
comprised by ten species that are distributed throughout Brazil. 
These species have been used mainly as ornamental plants, 
for instance, A. cathartica L., A. schottii Pohl and A. blanchetii 
A.DC. (Endress and Bruyns, 2000; Gonçalves and Lorenzi, 2007). 
The ethnopharmacological use of Allamanda genus is related 
to its latex as a scabicide and in lice control. The infusion of 
the flowers is purgative and is also used as an anti-helminthic, 
and as a topical agent it is used to reduce hyperthermia. 
The stems are used against hepatic tumors (Correa Jr et al., 
1984; Moreira, 1985; Rahayu, 2001; Lorenzi and Matos, 2002). 
Allamanda cathartica L. has long been used for different 
purposes, including the treatment of hepatic tumors, as it has 
low acute toxicity in rats > 30g/kg (Lopes et al., 2009).
Plants belonging to the Allamanda genus are known 
to produce iridoids, mainly plumericin, which has been 
documented to have antineoplastic, antileukemic, anti-
inflammatory, antimicrobial, and antileishmanial activities 
(Anderson et al., 1988; Hamburger et al., 1991; Castillo et al., 
2007; Kuete and Efferth, 2011). 
The iridoid glycoside, plumieride has gained interest 
because of its antidermatophytic and antitumor activities 
(Tiwari et al., 2002; Dobhal et al., 2004). In addition to iridoids, 
other classes of secondary metabolites produced by this genus 
are terpenes, flavonoids and coumarins (Anderson et al., 1988; 
Ganapaty et al., 1988; Kardono et al. 1990; Schmidt et al., 2006).
The ethanol extract of the roots of A. cathartica has been 
shown to be active in vivo against leukemic cells P-388 and 
in vitro against cells derived from human nasopharyngeal 
carcinoma (KB) (Kupchan et al., 1974). Our group has previously 
observed an anti-proliferative effect of the ethanol extract 
from different parts of A. schottii and A. blanchettii (leaf, stem 
and root) on human erythromyeloblastoid leukemic cells 
(K562), as well as on bone marrow endothelial cells (BMEC) 
and human umbilical cord endothelial cells (HUVEC). The 
results demonstrated the cytostatic and cytotoxic effect of the 
ethanol extract of A. schottii roots, at concentrations of < 80 and 
< 8 μg/ml, respectively. The cytotoxic effects of the leaf and 
stem extracts were at least ten times lower than these values 
(Schmidt et al., 2006). Therefore it is of great importance to 
investigate the antitumoral effects of this genus. 
In this context the aim of this research was to evaluate the 
extracts and fractions obtained from the leaf, stem and root of 
A. schottii responsible for cytotoxic activities, using several cell 
lines. The cytotoxicity to K652 cells was analyzed in relation to 
the season of the year and the part of the plant used, and the 
major constituents were elucidated. 
Materials and methods
Plant material 
Different parts (leaves, stems, and roots) of Allamanda schottii 
Pohl, Apocynaceae, were collected in Blumenau, a city in the 
state of Santa Catarina, Brazil, on March 23, June 19, September 
17 and December 22, 2006 corresponding to the end of summer, 
autumn, winter and spring, respectively. The plant material 
was classified by Prof. Oscar Benigno Iza (Universidade do 
Vale do Itajaí), and voucher specimens were deposited at the 
Barbosa Rodrigues Herbarium (HBR, Itajaí), under identifier 
HBR 52525. All plants analyzed were planted on the same day 
under the same environment, and collected after four years. 
After plant collection, each part was separately dried at room 
temperature. 
Preparation of extracts and fractions
The dried vegetal material (100 g) of each part (leaves, stems 
and roots) of A. schottii collected at the end of each season 
was macerated with 95% ethanol at room temperature, for 
seven days. Solvent removal was carried out under reduced 
pressure at temperatures below 45°C, until the desired 
concentrations were achieved, in order to obtain the ethanol 
extracts. A fraction of each extract was dissolved separately in 
methanol and water (90:10) and was successively partitioned 
using n-hexane, dichloromethane and ethyl acetate to obtain 
the respective fractions, after the removal of solvents. The 
samples were stored under refrigeration and protected from 
light until analysis. 
Isolation and identification of components
The ethanol extract of the stems (15.1 g) collected at the end of 
winter (September) of 2006 was chromatographed in a silica-gel 
column with n-hexane, ethyl acetate, and ethanol as solvents. 
The fraction eluted with n-hexane and ethyl acetate (8:2) 
yielded, after crystallization, a mixture of E-sitosterol and 
stigmasterol (36.5 mg). The fraction eluted with n-hexane 
and ethyl acetate (7:3) yielded plumericin (15.2 mg). Elution 
with n-hexane and ethyl acetate at a ratio of 6.5:3.5 yielded 
ursolic acid (62.4 mg), and at a ratio of 6:4 the sterol 3-O-E-
glucopyranosyl-sitosterol (9.2 mg) was obtained. The fraction 
eluted with ethyl acetate and ethanol (8:2) yielded plumieride 
(39.4 mg). In the subsequent fractions mixtures of sugars were 
isolated. 
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All the compounds were identified based on their spectral 
data, by comparison with the literature (Malheiros et al. 1997, 
Schmidt et al., 2006) and direct comparison with original 
samples.
LC Analysis
The analysis was conducted using a high performance liquid 
chromatography (HPLC) system (Waters) equipped with a 600-F 
pump and 717 plus autosampler with an in-line degasser (AF) 
and coupled to a UV-Vis detector (PDA 2996). A C18 column 
(25 cm, 4.6 mm i.d.; 0.5 μm film thickness and 100 A) was 
used (Luna, Phenomenex) at 25°C. The gradient system used 
consisted of a mixture of solvents A (acetonitrile 10%), B 
(methanol) and C (water acidified with phosphoric acid at pH 
3.54), starting with 10% B and 80% C at a flow rate of 0.8 ml/
min. The linear solvent gradient increased to 20% B and 70% 
C in 10 min; 35% B and 55% C in 10 min; 50% B and 40% C in 
15 min and 70% B and 20% C in 20 min maintained until the 
end of the run. After each analysis, 45% of mobile phase B 
was pumped and maintained for 10 min to re-equilibrate the 
system for baseline stability. UV-Vis spectra were recorded 
at a wavelength range of 200-400 nm (detection wavelength 
was 230 nm). The solvents used were HPLC grade (high purity), 
filtered (0.2 μm, Schleicher & Schuell, Maidstone, Kent, UK) 
and degassed by sonication before use. The samples of the 
dichloromethane and ethyl acetate fraction (1.0 mg/ml), and 
standard plumieride and plumericin (100 μg/ml) were dissolved 
using a mixture of the solvents A:B:C at proportion of 10:10:80. 
Each solution was then filtered through a 0.45 μm membrane 
filter and 20 μl aliquots were analyzed in triplicate. 
Cytotoxicity assay
Cell viability was assessed by performing 3-(4,5-dimethylthiozol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Mosmann, 1983) 
assays to determine the IC50 concentrations of the studied 
agents on the probit model (Finney, 1971). In these assays, non-
tumoral L929 fibroblast cells (Mus musculus), B16F10 melanoma 
(Mus musculus), HeLa from cervix adenocarcinoma and 
mammary carcinoma cells MCF-7 (Homo sapiens), all from the 
Cell Bank of Rio de Janeiro-BCRJ, were plated in 96-well plates. 
Human erythromyeloblastoid leukemia (K562) and human 
pre-B leukemia (Nalm6) cell lines were plated at a density of 
10,000 cells per well. The cells were treated with the ethanol 
extracts of the roots, stems and leaves, with the n-hexane, 
dichloromethane and ethyl acetate fractions, and with the 
isolated compounds plumericin, ursolic acid and plumeiride in 
MEM culture medium (Invitrogen/GIBCO) supplemented with 
10% heat-inactivated fetal calf serum (FCS), 1% antibiotic PSN 
(penicillin, streptomycin and neomycin) solution (Invitrogen/
GIBCO). Cells were cultured in 96-well plates, and grown for 
48 h at 37°C and 5% CO2. For negative controls (100% viability) 
the cells were incubated with the maximum amount of the 
diluent and MEM used. Paclitaxel (antitumor, melanoma and 
adenocarcinomas), Gleevec (K562) and vincristine (Nalm-6) 
were used as positive controls. The concentration leading to 
50% inhibition of viability (IC50) after 48 h was determined 
by measuring the absorbance at wavelength of 570 nm as an 
indicator of MTT reductase activity (Mosmann, 1983), using 
an Asys Hitech microplate reader. The viability of the treated 
cells was expressed as a percentage relative to the viability of 
control vehicle-treated cells. Each experiment was performed 
in triplicate and independently repeated at least three times.
Statistical analysis
The results are expressed as mean values ± SD from separate 
experiments. Group differences were determined by analysis 
of variance (ANOVA). Statistically significant differences were 
indicated by ANOVA, and the values were compared using 
the Tukey’s test. The differences were considered statistically 
significant at p < 0.05.
Results and discussion
Selection of the cytotoxic extract and fractions
To evaluate the cytotoxic activity of Allamanda schottii Pohl, 
Apocynaceae, human erythromyeloblastoid leukemia (K562), 
human pre-B leukemia (Nalm6), cervix adenocarcinoma (HeLa) 
cell lines and non-tumoral murine fibroblast (L929), were 
incubated with the ethanol extracts of the roots, stems and 
leaves collected in September, which is the end of winter in 
Brazil. After 48 h, cell viability was determined by the MTT 
assay. The IC50 values (μg/ml) are listed in Table 1. The values 
of total degree of inhibition to extracts established by Fouche 
et al. (2008) were used as a reference for data analysis of IC50. 
The ethanol extract of the roots had an IC50 value of 11.20 ± 
3.50 μg/ml for the HeLa cells. The stem and leaf extracts were 
most active against leukemic cell Nalm6, with IC50 values of 
30.00 ± 4.00 and 30.80 ± 1.10 μg/ml, respectively. The stem and 
leaves extracts were not active against K562 cells (IC50 > 100 
μg/ml) nor the non-tumoral cells (L929). 
These results indicate that cell lines differ in their 
sensitivity toward the same plant extract. Studies carried out 
by Schmidt et al. (2006) observed a more pronounced cytostatic 
and cytotoxic activity of the ethanol extract of roots from 
A. schottii in comparison with extracts of the stems, and a 
negligible effect of leaf extracts, against K562 leukemic cells, 
bone marrow endothelial cells (BMEC) and human umbilical 
cord endothelial cells (HUVEC). These differences in activity 
could be related to seasonal influence. The results found by 
Schmidt et al. (2006), when compared with our study, confirms 
that seasonal effects influence cytotoxicity.
The extracts that gave IC50 values below 100 μg/ml, in at 
least one tumor cell line, were partitioned with n-hexane, 
dichloromethane (DCM) and ethyl acetate (EtOAc) and the 
fractions were then evaluated in the same cells. As observed in 
Table 1 the main bioactive compounds were found in the DCM 
fractions in all parts of the plant studied, there being a significant 
reduction in the IC50 values for cells in which the extracts were 
active. Surprisingly, the DCM fractions were also active against 
the K562 cells, to which the extracts were not active. 
In the case of the DCM fraction of the roots there was no 
significant difference in the IC50 value when compared to the 
control drugs paclitaxel, gleevec and vincristine in relation to 
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Compounds
IC50 (μg/ml)
L929 HeLa K562 Nalm6
Ethanolic extract of roots 55.80 ± 8.10 11.20 ± 3.50 > 100 109.00 ± 0.40
n-Hexane fraction - - > 100 38.40 ± 4.00
Dichloromethane fraction 30.50 ± 3.50 6.30 ± 3.00 1.00 ± 0.80 1.20 ± 0.80
Ethyl acetate fraction - - > 100 35.00 ± 7.10
Ethanolic extract of stems > 100 > 100 > 100 30.00 ± 4.00
n-Hexane fraction - - 45.00 ± 3.50 46.00 ± 8.20
Dichloromethane fraction 65.60 ± 9.50 14.50 ± 3.00 4.90 ± 1.20 0.20 ± 0.01
Ethyl acetate fraction - - 41.00 ± 3.30 7.40 ± 1.30
Ethanolic extract of leaves > 100 > 100 > 100 30.80 ± 1.10
n-Hexane fraction - - 55.30 ± 6.10 74.40 ± 1.30
Dichloromethane fraction > 100 53.70 ± 0.10 46.80 ± 1.20 6.40 ± 2.30
Ethyl acetate fraction - - > 100 28.50 ± 1.30
Paclitaxel 3.84 ± 0.01 3.06 ± 0.54 - -
Gleevec - - 0.10 ± 0.04 -
Vincristine - - - 0.06 ± 0.04
Not available (-). Data are expressed as mean ± standard deviation of three determinations. 
Table 1
Cytotoxic effect (IC50) of extracts and fractions of different parts of the plant Allamanda schottii collected in winter against L929, 
HeLa, K562 and Nalm6 cell lines.
shown. This appears to be a cytotoxic synergy operating in 
the DCM fraction.
The activity of the isolated compounds toward B16F10 
melanoma and breast adenocarcinoma cells MCF-7 was 
also evaluated. The best results were found for plumericin 
and ursolic acid in the case of B16F10 cells with IC50 values 
of 3.80 ± 1.70 and 13.60 ± 1.30 μM, respectively. However, 
comparatively, paclitaxel was more cytotoxic to this cell line 
(p < 0.01). Although the activity against B16F10 cells was lower 
than that of the reference drug, the results observed against 
melanoma cells are of considerable interest, since plumericin 
could be used as a model for new derivatives to improve the 
effectiveness of cytotoxicity studies in relation to this highly 
invasive and metastatic type of cancer.
Abdel-Kader et al. (1997) documented low cytotoxicity of 
plumericin and isoplumericin against a lung carcinoma (M109) 
cell line (IC50 100 μg/ml). Anderson et al. (1988) isolated the 
iridoids plumericin, isoplumericin, allamandin and allancin 
from A. schottii and these compounds showed antitumoral 
activity against KB cells, confirming the importance of the 
use of different cell models in cytotoxic studies. Additionally, 
Gomes (2008) observed no evidence of mutagenicity in 
Salmonella typhimurim tests for plumericin, with or without 
metabolic activation with S9 and using the strains TA98, 
TA97a, TA100 and TA102. This result could be considered 
a determining factor for future in vivo studies with this 
iridoid. Another determining factor is the bioavailability of 
the compounds. According to Liao et al. (2005), the ursolic 
acid concentration in rat plasma, after oral administration, 
is extremely low; this implies that ursolic acid has high 
binding activity in organs and low blood distributions, and/or 
it is metabolized by the gut wall and liver, and/or it is poorly 
absorbed by the intestine. No information about the plumericin 
bioavailability was found in current literature.
HeLa, K562 and Nalm6 cells, respectively (p > 0.05). Similar IC50 
values were observed for the DCM fraction of the stems compared 
to gleevec and vincrisctine in relation to K562 and Nalm6 cells, 
respectively (p > 0.05), or in the DCM fraction of the leaves and 
vincristine in relation to Nalm-6 cells (p > 0.05). These outstanding 
results indicate that the DCM fraction elicits a similar activity to 
commercial drugs, strongly suggesting the presence of bioactive 
compounds in this fraction, which may be acting in isolation or 
in synergy to produce the considerable effect observed. 
Identification of active compounds in DCM fraction
Due to the observed cytotoxic activity described above, the 
ethanol extract of the stems, collected at the end of winter, 
was fractioned using open column chromatography. From 
this procedure a mixture of E-sitosterol and stigmasterol, 
plumericin, plumieride, ursolic acid, 3-O-E-glucopyranosyl-
sitosterol and a mixture of sugars were obtained. The 
compounds were analyzed by nuclear magnetic resonance 
(NMR) and their chemical shifts were compared with those 
found in the literature or with data of the standards previously 
isolated (Ganapaty et al., 1988, Abdel-Kader et al., 1997, 
Malheiros et al., 1997, Schmidt et al., 2006).
To determine the relationship between the cytotoxicity of 
the A. schottii extracts, fractions and their composition, the 
principal compounds isolated, plumericin, plumieride, and 
ursolic acid, were evaluated using different cell lines. The 
results are presented in Table 2. 
The cytotoxic effects of plumericin and ursolic acid suggest 
that these compounds are cytotoxic to HeLa and Nalm6 cells, 
respectively observed in the DCM fractions from different parts 
of the plant. In the K562 cells, the isolated compounds did not 
contribute to the effects observed. Other minor compounds 
still not identified may be co-responsible for the activity 
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Compounds
IC50 μM
MCF-7 B16F10 L929 HeLa K562 Nalm6
Plumericin (2) 121.7 ± 60.0 3.8 ± 1.7 161.9 ± 25.5 24.5 ± 13.4 111.1 ± 27.6 92.4 ± 10.7
Plumieride (1) > 212 > 212 > 212 > 212 > 212 > 212
Ursolic acid - 13.6 ± 1.3 - - > 219 66.8 ± 24.8
Paclitaxel 1.5 ± 0.6 0.4 ± 0.4 4.5 ± 1.6 3.6 ± 0.5 - -
Gleevec - - - - 0.5 ± 0.1 -
Vincristine - - - - - 0.15 ± 0.06
Not available (-). Data are expressed as mean ± standard deviation of three determinations.
Table 2
Cytotoxic effect (IC50) of compounds plumericin, plumieride and ursolic acid isolated from Allamanda schottii against, MCF-7, 
B16F10, L929, HeLa ,K562, Nalm6 cell lines.
Figure 1 – Season and toxicity of dichloromethane fractions of 
Allamanda schottii on K562 cells (IC50 in μg/ml).
Although plumericin plays an important role in the 
activity of the DCM fraction, other active compounds are also 
significant contributors, indicating synergy, which supports 
the phytotherapeutic use of the fraction rather than the 
isolated compounds. As observed in our results, the toxicity 
of species of the Allamanda genus is also related to the ursolic 
acid content. This compound was evaluated in relation to 
melanoma B16 by Saady et al. (1996) and showed significant 
cytotoxicity. It has also been documented to have activity as a 
suppressor of tumorigenesis, inhibitor of tumor promotion and 
suppressor of angiogenesis. The cytotoxicity may be related to 
the inhibition of DNA replication, activation of caspases, and 
induction of Ca2+ release (Hsu et al., 2004; Yim et al., 2006). 
Additionally, ursolic acid reportedly caused a 76% reduction in 
the number of micronuclei induced by mitomycin D (Guevara 
et al., 1996).
Plumieride was analyzed in all cell lines and did not present 
any sign of cell cytotoxicity by MTT. Dobhal et al. (2004) 
modified the plumieride structure, to enhance its activity. 
The results showed that, in the case of the fibrosarcoma (RIF) 
tumor cell line, the native molecule had an IC50 value of 49.5 
μg/ml, but the pentacetate analogue showed improved activity 
(IC50 19.5 μg/ml). The hydrolysis of the methylester did not 
make any significant difference to the efficacy (IC50 22 μg/
ml). When the log p values were increased (from propyl to 
dodecylamide analogues), a more effective activity (IC5011.8 
μg/ml) was observed.
Seasonal influence on cytotoxicity
Considering that seasonal changes can affect the production of 
secondary metabolites, A. schottii was harvested at the end of 
each season throughout 2006, and each of the extracts obtained 
from the roots, stems and leaves were fractioned with n-hexane, 
DCM and AcOEt. The DCM fractions relating to the four seasons 
were evaluated using leukemia cell lines K562. This cell line was 
selected due to its previously described resistance to apoptosis, 
and because it is a good indicator of the cytotoxic compounds 
of interest. The results are presented in Fig. 1.
For the root and stem DCM fractions, IC50 values of below to 
10 μg/ml were observed, independently of the season, except 
for the stem of DCM fraction obtained from plants collected in 
spring, with IC50 values of up to 30 μg/ml. The IC50 values for 
the DCM fractions of the leaves were between 20 and 40 μg/
ml. These results confirm the relation between the chemical 
composition or concentration of active principles at different 
seasons and their cytotoxic effect. The variability observed 
in the concentration of compounds could be related to 
environmental conditions such as climatic differences, stress 
levels, water availability, light, and natural predators (Gobbo-
Neto and Lopes, 2007).
To define the chemical composition of the DCM fractions 
obtained from the different parts of the plants collected at 
different seasons of the year, the HPLC analysis was conducted 
as an alternative means to analyze the quality the plant 
extracts. The chromatograms obtained are presented in Fig. 2
The chromatographic method developed in this study was 
used to evaluate the production of secondary metabolites 
present in Allamanda schottii, iridoids, which are the target of 
this study. The dichloromethane fraction of stems obtained in 
winter was analyzed in a series of mobile phases with different 
solvent systems to obtain a chromatogram with good peak 
separation. The phase with the best chromatogram consisted 
of a mixture of methanol, acetonitrile and ultrapure water 
acidified with phosphoric acid at pH 3.54. The absorbance 
at wavelength 230 nm was measured, since this is the best 
wavelength to obtain iridoids. 
The chromatographic profiles of A. schottii were very similar 
for each part examined at different seasons, differing in most 
cases only in terms of some peaks’ intensities. Since there 
is a direct relationship between chromatographic peak area 
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and analyte concentration, a difference in the phytochemical 
concentrations could be observed.
A total of 24 peaks at between 15 and 52 min were detected 
in the chromatograms of the DCM fractions (Fig. 2) at a 
wavelength of 230 nm. The identification of the iridoids was 
carried out by comparison of the UV spectra and retention 
time of previously isolated iridoids plumieride (1) and 
plumericin (2), injected under the same analysis conditions. 
The plumieride presented RT 18.3 ± 1.0 min and plumericin 
RT 43.0 ± 1.0 min (peak max. 215 nm). The peaks related to 
the two substances were identified by numbers 1 and 2, 
respectively, on the chromatograms of the dichloromethane 
fractions evaluated. The UV spectra for peaks a, b, c and d in 
the dichloromethane fraction were similar to plumericin and 
plumieride (data not shown). Therefore, it can be concluded 
that these metabolites are iridoids. The iridoids detected 
mainly in the dichloromethane fraction, especially in the case 
of this species, were aglycones. These iridoids, in general, 
were found mainly in the roots and stems, and in lower 
concentrations in the leaves. Plumericin (2) was found in all 
parts of the plant collected at all seasons, and the highest 
concentration was found in the roots. The influence of 
seasonality on this iridoid can be observed in the leaf extracts 
since during the summer, this iridoid was obtained in lower 
proportions.
Several iridoid aglycones have been isolated from plants 
of the genus Allamanda, including allamandin, allancin, 
fulvoplumierin and protoplumierin (Kupchan et al., 1974; 
Anderson et al., 1988; Tan et al., 1991). The iridoids exhibit 
several types of pharmacological activities including anti-
inflammatory, analgesic, antibacterial, antifungal and antitumor 
action, as well as sedative, tranquilizing and sleep-inducing 
properties, also they are uses for the treatment of hepatic 
dysfunctions (Ghisalberti, 1988; Dewick, 2002; Dinda et al., 2007).
The relation between the chromatographic profiles and 
toxicity of the DCM fractions against K562 leukemic cells may 
be associated with the presence of the iridoid plumericin. The 
qualitative analysis of plumericin by chromatography can 
provide information on the cytotoxic activity, since higher 
concentrations of this substance are related to increased 
Figure 2 – Chromatographic profiles of dichloromethane (DCM) fractions of Allamanda schottii collected at different seasons, 
acquired by HPLC O= 230 nm. a) DCM fractions of leaves, b) DCM fractions of stem, c) DCM fractions of root (plumieride (1) and 
plumericin (2), a, b, c and d iridoids not identified). For HPLC conditions see experimental procedures.
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activity. The roots collected in winter gave the best results 
against K562, and this fraction contained a high concentration 
of plumericin. The concentration in the stems is similar to that 
of the roots, except for the stems collected in spring. The leaves 
were found to contain lower concentrations of this metabolite, 
mainly in plants collected during summer. 
As shown in Table 2, the iridoid glycoside plumieride 
showed cytotoxic effect at concentrations greater than 
212 μM (> 100 μg/ml). These values are quite high when 
compared to the activity observed for plumericin against, for 
example, to B16F10 cells (3.8 μM). Plumieride was detected in 
dichloromethane spring, autumn and summer stems fractions 
and in the ethyl acetate fraction from the stems collected 
in autumn, winter and spring (chromatograms of the ethyl 
acetate not shown). The dichloromethane and ethyl acetate 
fractions analyzed presented IC50 values inferior to 50 μg/ml, 
especially to leukemic cells K562 and Nalm-6 (except the ethyl 
acetate fractions of roots and leaves against K562 cells). These 
results indicate that plumieride does not contribute to the 
cytotoxic activity observed in these fractions. Plumericin can 
contribute, in part, to this activity. This compound exhibited a 
cytotoxic effect at concentrations 3.8 ± 1.7 μM to B16F10 cells
The results for the cytotoxicity of A. schotti extracts need 
to be correlated with the season of the year, the fraction 
and the part of the plant evaluated, as these three factors 
are determinant in terms of cytotoxicity. The presence of 
plumericin and ursolic acid in the roots, as well as in other 
parts of the plant, particularly in the DCM fraction, appears to 
be a major factor responsible for the cytotoxicity observed. The 
results clearly show the phytotherapeutic potential use of the 
plant, due to synergy or the presence of minority compounds 
not yet identified, as well as the seasonal influence on the 
production of secondary metabolites. 
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